Diagnostics companies at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
55 diagnostics companies are at SABCS 2026 — 50 presentations on the program and 27 with a booth in the exhibit hall. Most represented: Myriad Genetics (5 on the program), Caris Life Sciences (2 on the program), Inocras (1 on the program). 29 of them have their own page in this guide. As of Nov 10, 2026.
Focus
Top represented
Showing 1–14 of 55 organizations
| Organization | SABCS 2026 Attendance |
|---|---|
Myriad Genetics Salt Lake City, UT | |
Molecular diagnostics company offering hereditary cancer risk tests, tumor tests that guide treatment, and women's health and pharmacogenomic screening. | Booth Exhibiting at Booth 215 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm Poster Thu Dec 10 12:30–2pm |
Caris Life Sciences Irving, TX | |
Molecular profiling company whose tissue and blood tests, backed by AI, map a tumor's DNA, RNA and proteins to guide cancer treatment. | Booth Exhibiting at Booth 1215 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 12:30–2pm |
Inocras San Diego, CA | |
Whole-genome sequencing company using its own analytics to turn genome data into clinical and research insights for precision health. | Booth Exhibiting at Booth 247 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 12:30–2pm |
NeoGenomics Fort Myers, FL | |
Cancer diagnostics company running CLIA-certified labs that offer a broad oncology testing menu to oncologists, pathologists, hospitals and drug developers. | Booth Exhibiting at Booth 242 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 5–6:30pm |
Tempus Chicago, IL | |
AI-driven precision medicine company offering genomic testing and data tools to physicians and helping drug developers with discovery and trials. | Booth Exhibiting at Booth 1332 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 12:30–2pm |
ARTIDIS Basel, Switzerland | |
Nanotechnology-based analysis of biopsy tissue, paired with a data platform, to help guide treatment of solid tumors. | Booth Exhibiting at Booth 849 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Astrin Biosciences Saint Paul, MN | |
Early cancer detection company whose Certitude blood test is designed to help find breast cancer early. | Booth Exhibiting at Booth 1534 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Natera San Carlos, CA | |
Cell-free DNA blood tests for cancer: tumor-informed MRD monitoring with Signatera, treatment response, genomic profiling and hereditary risk. | Booth Exhibiting at Booth 909 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
PreludeDx Laguna Hills, CA | |
Genomic tests that help decide on surgery and radiation: DCISionRT in DCIS and AidaBreast in early invasive breast cancer. | Booth Exhibiting at Booth 1208 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Agendia Irvine, CA | |
Genomic tests for early-stage breast cancer, including MammaPrint and BluePrint, that help clinicians weigh recurrence risk and choose treatment. | Booth Exhibiting at Booth 1242 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Artera Los Altos, CA | |
Multimodal AI tests that read digitized pathology slides alongside clinical data to judge how aggressive a cancer is and who benefits from therapy. | Booth Exhibiting at Booth 1544 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Ataraxis New York, NY | |
AI tests that read routine pathology slides and patient data to estimate outcomes and guide treatment in every subtype of invasive breast cancer. | Booth Exhibiting at Booth 1524 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Bio-Techne Diagnostics Austin, TX | |
Asuragen molecular diagnostic kits and software, including the QuantideX line for cancer monitoring and diagnosis, run on widely installed lab instruments. | Booth Exhibiting at Booth 1430 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Biovica Uppsala, Sweden | |
Maker of DiviTum TKa, a blood test of tumor cell growth that tracks treatment response in metastatic hormone receptor-positive breast cancer. | Booth Exhibiting at Booth 1252 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Find buyers from diagnostics companies
Tell us what you sell and we’ll find the people at these diagnostics companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SABCS 2026 by
Organization type
Focus
- Genomic and tumor testing 160
- Hormone receptor-positive breast cancer 157
- Triple-negative breast cancer 99
- Patient and family support 96
- Breast surgery and biopsy 93
- HER2-positive breast cancer 81
- Hereditary risk and genetic testing 64
- AI and data 60
- Clinical trials and research 58
- Metastatic breast cancer 54
- Side effects and supportive care 46
- Screening and early detection 39
- Liquid biopsy and MRD 11
Exhibit hall
Everyone
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction